RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
This Quarter Return
+13.52%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.86B
AUM Growth
+$1.86B
(+9.1%)
Cap. Flow
-$9.15M
Cap. Flow
% of AUM
-0.49%
Top 10 Holdings %
Top 10 Hldgs %
25.53%
Holding
256
New
8
Increased
83
Reduced
146
Closed
9
Top Buys
| 1 |
Chart Industries
GTLS
|
$15.9M |
| 2 |
WIX.com
WIX
|
$14M |
| 3 |
Vail Resorts
MTN
|
$7.04M |
| 4 |
Ziff Davis
ZD
|
$6.98M |
| 5 |
WEX
WEX
|
$6.62M |
Top Sells
| 1 |
VRNA
Verona Pharma
VRNA
|
$20.3M |
| 2 |
Stride
LRN
|
$19.1M |
| 3 |
RB Global
RBA
|
$8.98M |
| 4 |
TKO Group
TKO
|
$7.98M |
| 5 |
Federal Agricultural Mortgage
AGM
|
$7.07M |
Sector Composition
| 1 | Healthcare | 31.2% |
| 2 | Technology | 28.31% |
| 3 | Industrials | 17.73% |
| 4 | Communication Services | 6.8% |
| 5 | Consumer Discretionary | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Chart Industries
GTLS
$8.96B
| $23.4M | 1.26% | 142,381 +96,406 | +210% | +$15.9M |
|
27
Radware
RDWR
$1.08B
| $22.2M | 1.2% | 754,135 -105,580 | -12% | -$3.11M |
|
28
Ituran Location and Control
ITRN
$671M
| $19.7M | 1.06% | 508,615 +18,698 | +4% | +$724K |
|
29
BioCryst Pharmaceuticals
BCRX
$1.74B
| $18.5M | 0.99% | 2,060,280 +32,712 | +2% | +$293K |
|
30
LeMaitre Vascular
LMAT
$2.16B
| $17.8M | 0.96% | 213,870 +3,248 | +2% | +$270K |
|
31
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $17.7M | 0.95% | 638,233 +13,688 | +2% | +$379K |
|
32
Supernus Pharmaceuticals
SUPN
$2.53B
| $16.5M | 0.89% | 524,647 +8,758 | +2% | +$276K |
|
|
33
Vail Resorts
MTN
$6.09B
| $16.3M | 0.88% | 103,915 +44,776 | +76% | +$7.04M |
|
34
ReposiTrak
TRAK
$296M
| $16.2M | 0.87% | 826,799 -26,218 | -3% | -$515K |
|
35
Amicus Therapeutics
FOLD
$2.34B
| $15.8M | 0.85% | 2,760,314 +750,210 | +37% | +$4.3M |
|
36
Ingevity
NGVT
$2.13B
| $15.8M | 0.85% | 365,637 +1,421 | +0.4% | +$61.2K |
|
37
CRA International
CRAI
$1.28B
| $15.6M | 0.84% | 83,312 +1,821 | +2% | +$341K |
|
38
Acadia Pharmaceuticals
ACAD
$4.38B
| $14.4M | 0.78% | 669,806 -2,417 | -0.4% | -$52.1K |
|
39
Shutterstock
SSTK
$742M
| $14.2M | 0.77% | 750,665 +84,317 | +13% | +$1.6M |
|
40
Neurocrine Biosciences
NBIX
$13.8B
| $13.6M | 0.73% | 108,382 -1,291 | -1% | -$162K |
|
|
NEXN
41
Nexxen International
NEXN
$636M
| $13.5M | 0.73% | 1,293,799 +407,968 | +46% | +$4.25M |
|
42
Bank OZK
OZK
$5.91B
| $13.2M | 0.71% | 281,013 -2,507 | -0.9% | -$118K |
|
43
Maximus
MMS
$4.95B
| $12.9M | 0.7% | 184,084 -1,696 | -0.9% | -$119K |
|
44
Franklin Covey
FC
$247M
| $12.2M | 0.66% | 533,711 +9,916 | +2% | +$226K |
|
45
Alkermes
ALKS
$4.78B
| $12.1M | 0.65% | 421,885 -4,700 | -1% | -$134K |
|
46
Mirum Pharmaceuticals
MIRM
$3.71B
| $11.8M | 0.64% | 231,993 -2,703 | -1% | -$138K |
|
47
Harrow
HROW
$1.44B
| $11.3M | 0.61% | 370,627 +74,455 | +25% | +$2.27M |
|
48
Gentex
GNTX
$6.15B
| $9.82M | 0.53% | 446,548 -4,462 | -1% | -$98.1K |
|
49
Pool Corp
POOL
$11.6B
| $9.71M | 0.52% | 33,312 -399 | -1% | -$116K |
|
50
CEVA Inc
CEVA
$531M
| $9.69M | 0.52% | 440,875 +5,397 | +1% | +$119K |
|